S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bovie Medical Co. stock logo
BVX
Bovie Medical
$6.48
+1.1%
$0.00
$2.28
$7.70
$215.14MN/A136,878 shs129,500 shs
(CLV) stock logo
CLV
(CLV)
$1.43
$0.00
$0.98
$7.17
N/AN/A265,405 shsN/A
CRH plc stock logo
CRH
CRH
$78.51
-0.8%
$81.82
$47.14
$88.00
$54.15B1.283.66 million shs2.36 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
(CLV) stock logo
CLV
(CLV)
0.00%0.00%0.00%0.00%0.00%
CRH plc stock logo
CRH
CRH
-1.36%-5.69%-5.05%+16.39%+59.63%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/AN/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/AN/AN/AN/AN/AN/AN/A
CRH plc stock logo
CRH
CRH
2.244 of 5 stars
2.43.01.70.02.91.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/AN/AN/A
CRH plc stock logo
CRH
CRH
2.75
Moderate Buy$79.311.02% Upside

Current Analyst Ratings

Latest CRH, CLV, and BVX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
CRH plc stock logo
CRH
CRH
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$80.00 ➝ $82.00
4/5/2024
CRH plc stock logo
CRH
CRH
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$101.00 ➝ $106.00
3/22/2024
CRH plc stock logo
CRH
CRH
Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$105.00
3/4/2024
CRH plc stock logo
CRH
CRH
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $95.00
3/4/2024
CRH plc stock logo
CRH
CRH
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$89.70 ➝ $100.00
1/19/2024
CRH plc stock logo
CRH
CRH
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$82.00
(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/AN/AN/AN/AN/A
CRH plc stock logo
CRH
CRH
$34.95B1.55N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/A0.00N/AN/AN/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/A0.00N/AN/AN/AN/AN/A
CRH plc stock logo
CRH
CRH
$3.18BN/A0.0013.561.36N/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/AN/AN/AN/A
CRH plc stock logo
CRH
CRH
$1.261.60%+12.14%N/AN/A

Latest CRH, CLV, and BVX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/29/2024
CRH plc stock logo
CRH
CRH
Variable$0.26202%3/14/20243/15/20244/17/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/A
(CLV) stock logo
CLV
(CLV)
N/AN/AN/A
CRH plc stock logo
CRH
CRH
N/A
1.69
1.26

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A
(CLV) stock logo
CLV
(CLV)
N/A
CRH plc stock logo
CRH
CRH
62.50%

Insider Ownership

CompanyInsider Ownership
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A
(CLV) stock logo
CLV
(CLV)
N/A
CRH plc stock logo
CRH
CRH
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A33.20 millionN/ANot Optionable
(CLV) stock logo
CLV
(CLV)
N/AN/AN/ANot Optionable
CRH plc stock logo
CRH
CRH
78,500689.69 millionN/AOptionable

CRH, CLV, and BVX Headlines

SourceHeadline
River Road Asset Management LLC Buys 654,643 Shares of CRH plc (NYSE:CRH)River Road Asset Management LLC Buys 654,643 Shares of CRH plc (NYSE:CRH)
marketbeat.com - April 17 at 4:32 PM
Are Construction Stocks Lagging CRH (CRH) This Year?Are Construction Stocks Lagging CRH (CRH) This Year?
finance.yahoo.com - April 17 at 2:32 PM
Are Construction Stocks Lagging CRH (CRH) This Year?Are Construction Stocks Lagging CRH (CRH) This Year?
zacks.com - April 17 at 10:46 AM
CRH (NYSE:CRH) Stock Rating Reaffirmed by Stifel NicolausCRH (NYSE:CRH) Stock Rating Reaffirmed by Stifel Nicolaus
americanbankingnews.com - April 17 at 2:30 AM
CRH plc (NYSE:CRH) Shares Sold by Desjardins Global Asset Management Inc.CRH plc (NYSE:CRH) Shares Sold by Desjardins Global Asset Management Inc.
marketbeat.com - April 16 at 3:48 PM
Stifel Downgrades CRH (CRH)Stifel Downgrades CRH (CRH)
msn.com - April 16 at 8:16 AM
CRHs (CRH) Hold Rating Reaffirmed at Stifel NicolausCRH's (CRH) Hold Rating Reaffirmed at Stifel Nicolaus
americanbankingnews.com - April 16 at 4:46 AM
Voss Capital LLC Has $122.41 Million Position in CRH plc (NYSE:CRH)Voss Capital LLC Has $122.41 Million Position in CRH plc (NYSE:CRH)
marketbeat.com - April 15 at 7:23 PM
CRH (NYSE:CRH) Earns "Hold" Rating from Stifel NicolausCRH (NYSE:CRH) Earns "Hold" Rating from Stifel Nicolaus
marketbeat.com - April 15 at 8:35 AM
LONDON BROKER RATINGS: UBS raises Crest Nicholson; Stifel cuts CRHLONDON BROKER RATINGS: UBS raises Crest Nicholson; Stifel cuts CRH
lse.co.uk - April 15 at 7:14 AM
CRH plc (NYSE:CRH) Short Interest UpdateCRH plc (NYSE:CRH) Short Interest Update
marketbeat.com - April 13 at 6:44 PM
Global Congenital Adrenal Hyperplasia Treatment Market Poised for Significant Growth, Reaching US$ 892 Million by 2033Global Congenital Adrenal Hyperplasia Treatment Market Poised for Significant Growth, Reaching US$ 892 Million by 2033
fmiblog.com - April 13 at 6:38 PM
READI grants: Local region awarded $30 million in economic development fundingREADI grants: Local region awarded $30 million in economic development funding
therepublic.com - April 13 at 6:38 PM
Don’t let stress get under your skinDon’t let stress get under your skin
financialexpress.com - April 13 at 6:38 PM
Aston Martin flies into a storm over fat cat perksAston Martin flies into a storm over fat cat perks
msn.com - April 13 at 6:38 PM
Sprucegrove Investment Management Ltd. Purchases New Position in CRH plc (NYSE:CRH)Sprucegrove Investment Management Ltd. Purchases New Position in CRH plc (NYSE:CRH)
marketbeat.com - April 13 at 12:39 PM
3 Things to Do If Stress Is Killing Your Appetite3 Things to Do If Stress Is Killing Your Appetite
msn.com - April 11 at 6:53 PM
CRH publishes quarterly U.S. GAAP information for 2023CRH publishes quarterly U.S. GAAP information for 2023
finance.yahoo.com - April 11 at 8:52 AM
CRH publishes quarterly U.S. GAAP information for 2023CRH publishes quarterly U.S. GAAP information for 2023
businesswire.com - April 11 at 7:00 AM
Is Shell trying to kill the London stock market?Is Shell trying to kill the London stock market?
theguardian.com - April 11 at 12:53 AM
CRH Boosts Presence in California With Two New AcquisitionsCRH Boosts Presence in California With Two New Acquisitions
zacks.com - April 8 at 9:56 AM
DekaBank Deutsche Girozentrale Buys 315,190 Shares of CRH plc (NYSE:CRH)DekaBank Deutsche Girozentrale Buys 315,190 Shares of CRH plc (NYSE:CRH)
marketbeat.com - April 7 at 10:11 AM
Citigroup Increases CRH (NYSE:CRH) Price Target to $106.00Citigroup Increases CRH (NYSE:CRH) Price Target to $106.00
americanbankingnews.com - April 7 at 4:16 AM
Compound Global Advisors LLC Has $24.19 Million Stock Position in CRH plc (NYSE:CRH)Compound Global Advisors LLC Has $24.19 Million Stock Position in CRH plc (NYSE:CRH)
marketbeat.com - April 5 at 8:49 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bovie Medical logo

Bovie Medical

NYSEAMERICAN:BVX
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
(CLV) logo
CRH logo

CRH

NYSE:CRH
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services. It also manufactures, supplies, and delivers solutions for the built environment in communities across North America; and offers building and infrastructure solutions serving complex critical utility infrastructure, such as water, energy, transportation, and telecommunications projects, and outdoor living solutions for enhancing private and public spaces. In addition, the company combines materials, products, and services to produce a wide range of architectural and infrastructural solutions for use in the building and renovation of critical utility infrastructure, commercial and residential buildings, and outdoor living spaces for the built environment. Further, it produces and supplies precast and pre-stressed concrete products comprising floor and wall elements, beams, vaults, pipes, and manholes; granite, limestone, and sandstone; concrete and polymer-based products, such as underground vaults, drainage systems, utility enclosures, and modular precast structures; engineered steel, polymer-based anchoring, fixing, and connecting solutions; concrete masonry, hardscape and related products, including pavers, blocks and curbs, retaining walls, and slabs; and fencing and railing systems, composite decking, lawn and garden products, and packaged concrete mixes. The company was founded in 1936 and is headquartered in Dublin, Ireland.